Ignite Creation Date:
2024-05-06 @ 1:42 AM
Last Modification Date:
2024-10-26 @ 11:08 AM
Study NCT ID:
NCT01874288
Status:
TERMINATED
Last Update Posted:
2020-11-24
First Post:
2013-06-07
Brief Title:
A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL
Sponsor:
Alopexx Oncology LLC
Organization:
Alopexx Oncology LLC
Organization Data
Organization:
Alopexx Oncology LLC
Class:
INDUSTRY
Study ID:
AO-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alopexx Oncology LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None